Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction—A Prospective Cohort Study

Whereas tenofovir disoproxil fumarate (TDF) can lead to renal adverse events, tenofovir alafenamide (TAF) has a more favorable renal safety profile. However, the impact of replacing TDF with TAF on renal function and liver parameters among HIV/hepatitis B virus (HBV)-coinfected individuals with rena...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Acquir Immune Defic Syndr
Main Authors: Surial, Bernard, Béguelin, Charles, Chave, Jean-Philippe, Stöckle, Marcel, Boillat-Blanco, Noémie, Doco-Lecompte, Thanh, Bernasconi, Enos, Fehr, Jan, Günthard, Huldrych F., Schmid, Patrick, Walti, Laura N., Furrer, Hansjakob, Rauch, Andri, Wandeler, Gilles
Formato: Artigo
Idioma:Inglês
Publicado em: JAIDS Journal of Acquired Immune Deficiency Syndromes 2020
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7495978/
https://ncbi.nlm.nih.gov/pubmed/32925387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002429
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados